25
total announcements
BALPHARMA.NS · 15 min delayed
Key Stats · Yahoo Finance · as of 15 Oct 2026
Market Cap
₹157 Cr
P/E (TTM)
21.7
EPS (TTM)
₹4.54
52W Low
₹60.00
52W High
₹124.60
Dividend Yield
1.21%
Beta
0.44
Price / Book
1.9
Debt / Equity
193.9
Revenue (TTM)
₹334 Cr
Gross Margin
47.50%
Operating Margin
5.83%
Bal Pharma Limited
Bal Pharma Limited has confirmed compliance with SEBI (Depositories and Participants) Regulations, 2018, by submitting details of dematerialized and rematerialized securities to stock exchanges within the prescribed time limit.
Bal Pharma Limited
Bal Pharma Limited has informed the Exchange regarding Notice of Postal Ballot for considering the issue of 10,00,000 Warrants to Mr. Shailesh Siroya, Promoter of the Company on preferential basis.
Bal Pharma Limited
Bal Pharma Limited has informed the Exchange that Mr. Shreepada ML has taken charge as the Company Secretary and Compliance Officer with effect from 23rd June 2026.
Bal Pharma Limited
Bal Pharma Limited has informed the Exchange regarding the closure of the trading window for dealing with the company's securities due to the declaration of unaudited financial results for the quarter ended 30/06/2026.
Bal Pharma Limited
The National Stock Exchange (NSE) has requested clarification from Bal Pharma Limited regarding its financial results for the quarter ended March 31, 2026, under Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The company's official response to this request is currently awaited. This indicates potential scrutiny or discrepancies in the reported financial statements.